UCLA Medical Center and ABIOMED, Inc. announced today that the principal investigators of the Los Angeles-based AbioCor clinical and research teams, Drs. Hillel Laks, Daniel Marelli, and Jaime Moriguchi, performed the world's fourth implantation of ABIOMED, Inc.'s, AbioCor Implantable Replacement Heart on Wednesday, October 17 at UCLA Medical Center.
UCLA Medical Center is one of five national sites participating in the Abiomed artificial heart transplant trial studies. The first two procedures were performed at Jewish Hospital in Louisville, Kentucky and the third implant took place at Texas Heart Institute and St. Luke's Episcopal Hospital in Houston. For additional background information, please visit our web site at www.artificialheart.ucla.edu.